Diaceutics PLC (DXRX) — Capital Reinvestment Ratio
Diaceutics PLC (DXRX) has a Capital Reinvestment Ratio of 0.07x as of June 2025, meaning it reinvests 0% of its operating cash flow (GBX800.00K) in capital expenditures (GBX55.00K). See how leveraged is Diaceutics PLC's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Diaceutics PLC Capital Reinvestment Ratio (2016–2024)
This chart tracks Diaceutics PLC's Capital Reinvestment Ratio across 7 annual periods. Check Diaceutics PLC (DXRX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Diaceutics PLC (2016–2024)
Year-by-year Capital Reinvestment Ratio for Diaceutics PLC from 2016 to 2024. For live market cap and broader valuation context, see Diaceutics PLC market capitalisation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.12x | GBX651.00K | GBX4.63 Million | ▲ +92.1% |
| 2023 | 3.70x | GBX1.31 Million | GBX4.86 Million | ▲ +287.5% |
| 2022 | 0.96x | GBX5.10 Million | GBX4.87 Million | ▼ -90.3% |
| 2021 | 9.83x | GBX570.00K | GBX5.60 Million | ▼ -60.5% |
| 2020 | 24.88x | GBX253.00K | GBX6.29 Million | ▲ +13390.3% |
| 2017 | 0.18x | GBX1.53 Million | GBX282.92K | ▲ +328.1% |
| 2016 | 0.04x | GBX674.01K | GBX29.03K | — |